ArticleIntestinal research2026

Comments on "Week 2 remission with vedolizumab as a predictor of long-term remission in patients with ulcerative colitis: a multicenter, retrospective, observational study".

Philippe PintonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.